Medicare Enrolled

Dr. Paul Holoye, M. D.

Name: Federal CMS public records for Dr. Paul Holoye (NPI 1497716401)
Creator: U.S. Centers for Medicare & Medicaid Services
License: https://www.usa.gov/government-works

Hematology & Oncology · McAllen, TX

Low-engagement

5401 N G ST STE 3, McAllen, TX 78504

9562177000

In practice since 2006 (20 years)

NPI: 1497716401 verify on NPPES ↗

High

DATA COVERAGE

Data in 3 of 4 federal sources

Measures public federal data availability — not provider quality

Informational, not a quality rating. This page presents federal public records about Dr. Holoye from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →

Are you Dr. Holoye? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Holoye

Dr. Paul Holoye is a hematology & oncology in McAllen, TX, with 20 years in practice.

Between the years covered by Open Payments, Dr. Holoye received a total of $6,160 from 61 pharmaceutical and/or device companies across 373 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Holoye is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice$ $6,160 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗

$6,160

Total received (2019-2024)

Avg $1,027/year across 6 years

Top 39% in TX for hematology & oncology

Companies

373

Individual payments

All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel

Food, beverages, travel, and lodging — typically low-value

$5,928 (96.2%)

Speaking / Promotional

Speaker programs, honoraria, and industry-sponsored educational events

$232 (3.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024

$605

2023

$765

2022

$1,364

2021

$1,356

2020

$1,231

2019

$839

Payments by company (2024)

Consulting

Speaking

Meals & Travel

Research

Merck Sharp & Dohme Corporation

$496

GENZYME CORPORATION

$388

Astellas Pharma US Inc

$369

PFIZER INC.

$362

Novartis Pharmaceuticals Corporation

$330

Amgen Inc.

$320

Janssen Biotech, Inc.

$302

Daiichi Sankyo Inc.

$242

AstraZeneca Pharmaceuticals LP

$234

Lilly USA, LLC

$229

Merck Sharp & Dohme LLC

$176

Dova Pharmaceuticals

$162

Rigel Pharmaceuticals, Inc.

$143

Gilead Sciences, Inc.

$126

Genentech USA, Inc.

$121

PUMA BIOTECHNOLOGY, INC.

$116

Karyopharm Therapeutics Inc.

$108

Ipsen Biopharmaceuticals, Inc

$107

Takeda Pharmaceuticals U.S.A., Inc.

$100

Incyte Corporation

$93

Celgene Corporation

$88

Bayer HealthCare Pharmaceuticals Inc.

$85

Eisai Inc.

$78

Myovant Sciences Inc.

$69

EISAI INC.

$69

Seagen Inc.

$66

MorphoSys, US Inc.

$62

BeiGene USA, Inc.

$61

Exelixis Inc.

$60

Coherus Biosciences Inc.

$57

ARRAY BIOPHARMA INC

$53

Nestle HealthCare Nutrition Inc.

$53

EMD Serono, Inc.

$47

GlaxoSmithKline, LLC.

$47

Puma Biotechnology, Inc.

$47

Kyowa Kirin, Inc.

$46

CTI BioPharma Corp.

$43

JAZZ PHARMACEUTICALS INC.

$42

Clovis Oncology, Inc.

$41

Kite Pharma, Inc.

$40

TAIHO ONCOLOGY, INC.

$39

SOBI, INC

$35

TerSera Therapeutics LLC

$33

Sobi, Inc

$29

Secura Bio, Inc.

$28

Deciphera Pharmaceuticals Inc.

$27

SpringWorks Therapeutics, Inc.

$26

SECURA BIO, INC.

$25

Myriad Genetic Laboratories, Inc.

$23

Roche Diagnostics Corporation

$23

Verastem, Inc.

$23

Telix Pharmaceuticals

$22

Alexion Pharmaceuticals, Inc.

$21

Taiho Oncology, Inc.

$19

Regeneron Healthcare Solutions, Inc.

$18

Boehringer Ingelheim Pharmaceuticals, Inc.

$17

Shire North American Group Inc

$17

Immunomedics, Inc.

$15

AbbVie Inc.

$15

AbbVie, Inc.

$13

Mirati Therapeutics, Inc.

$13

Top 3 companies account for 20.3% of total payments

Associated products mentioned in payments ›

ADCETRIS · ALIMTA · Aliqopa · BALVERSA · BLENREP · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Balversa · Bavencio · CABLIVI · CALQUENCE · COPIKTRA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DIS navify software · DOPTELET · Doptelet · ELITEK · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · Enhertu · FRUZAQLA · Farydak · GAZYVA · GILOTRIF · IBRANCE · ILLUCCIX · IMBRUVICA · IMJUDO · INLYTA · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Nplate · OGSIVEO · ONUREG · ORGOVYX · PADCEV · PIQRAY · POTELIGEO · PROMACTA · Polivy · Prolia · QINLOCK · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · Stivarga · TASIGNA · TUKYSA · Tavalisse · Tecentriq · Trodelvy · Turalio · Udenyca · VENCLEXTA · VERZENIO · VPRIV · Vectibix · Venclexta · Vonjo · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xtandi · ZENPEP · ZEPZELCA

Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology in McAllen?
Compare hematology & oncologys in the McAllen area by procedure volume, costs, and industry payment transparency.

Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi

Per 100K population

1.2

County median income

$52,281

Nearest hospital

SOUTH TEXAS HEALTH SYSTEM
3.4 mi

Data Sources

Provider Registry	✓ NPPES	Weekly updates
Medicare Enrollment	✓ PECOS	Monthly updates
Practice Data	— No data	N/A
Industry Payments	✓ Open Payments	CY 2024
Disciplinary History	— Not public	N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Holoye is a hematology & oncology, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Holoye receive payments from pharmaceutical companies?

Yes. Dr. Holoye received a total of $6,160 from 61 companies across 373 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

What does Data Coverage mean?

Data Coverage (currently High for Dr. Holoye) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →

Is this data up to date?

Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city

Hematology & Oncologys in McAllen

Browse hematology & oncologys in McAllen ranked by procedure volume and transparency data.

Highest volume

Top Hematology & Oncologys in TX

Hematology & Oncologys ranked by total Medicare services performed statewide.

Industry payments

Pharma Payments to Hematology & Oncologys in TX

Which TX hematology & oncologys receive the most from drug and device companies.

By company

Merck Sharp & Dohme Corporation Payments to Doctors

See all physicians who received payments from Merck Sharp & Dohme Corporation.

By company

GENZYME CORPORATION Payments to Doctors

See all physicians who received payments from GENZYME CORPORATION.

By company

Astellas Pharma US Inc Payments to Doctors

See all physicians who received payments from Astellas Pharma US Inc.

About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology